Virus News and Research

Latest Virus News and Research

Study reveals new way viruses trigger autoimmunity

Study reveals new way viruses trigger autoimmunity

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Antibody prevalence found to be highest among secondary school students in England

Antibody prevalence found to be highest among secondary school students in England

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Will Omicron BA.2 become the next dominant variant?

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

The epidemiology of COVID-19 in Africa

The epidemiology of COVID-19 in Africa

A promising new vaccine for SARS-CoV-2 and influenza

A promising new vaccine for SARS-CoV-2 and influenza

New study tests effectiveness of behavioral interventions in a pandemic-like simulation

New study tests effectiveness of behavioral interventions in a pandemic-like simulation

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Research could pave the way for adoption of precision medicine approaches for COVID-19

Research could pave the way for adoption of precision medicine approaches for COVID-19

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.